-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

615.P1.33 615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster I

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, AML, Biological, therapy sequence, Diseases, Non-Biological, Combinations, Elderly, Therapies, chemotherapy, MDS, Pediatric, Technology and Procedures, Lymphoid Malignancies, Study Population, Clinically relevant, Myeloid Malignancies, palliative care, TKI, NGS
Saturday, December 5, 2020: 7:00 AM-3:30 PM

Tara Lin, MD1, Gabriel N. Mannis, MD2, Harry P. Erba3, Mark Levis, MD, PhD4, Heng Zou5*, Stefan Faderl5, Ronald S. Cheung5 and Vinod A. Pullarkat, MD6

1University of Kansas Medical Center, Kansas City, KS
2Stanford University Medical Center, Palo Alto, CA
3Duke University School of Medicine, Durham, NC
4Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
5Jazz Pharmaceuticals, Palo Alto, CA
6City of Hope Comprehensive Cancer Center, Duarte, CA

Elias Jabbour, MD1, Giovanni Martinelli, MD2, Marco Vignetti, MD3*, Hagop M. Kantarjian, MD4, David Gomez-Almaguer, MD 5, Yosuke Minami, MD, PhD6, Hervé Dombret, MD7, Bingxia Wang, PhD8*, E. Jane Leonard, MSc8*, Shouryadeep Srivastava, MBBS, PhD8* and Josep-Maria Ribera9

1The University of Texas MD Anderson Cancer Center, Houston, TX
2Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRST IRCCS, Meldola, Italy
3GIMEMA Research Foundation, Rome, Italy
4Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
5Hospital Universitario (UANL), Monterrey, Mexico
6National Cancer Center Hospital East, Kashiwa, Japan
7Institut de Recherche Saint Louis, Université de Paris, Paris, France
8Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
9Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Barcelona, Spain

Thomas Moehler, MD, PhD1*, Magdalena Ruiz, MD, MSc2*, Vicky Casey3*, Luana Margotto Soares4*, Fil Manuguid5*, Kriti Jindal, MS6* and Sari Heitner Enschede, MD7

1Medical and Scientific Services Hematology/Oncology, IQVIA RDS GmbH, Frankfurt am Main, Germany
2Medical and Scientific Services, DSSR, IQVIA, Madrid, Spain
3Data Science & Advanced Analytics, IQVIA, London, United Kingdom
4Global Primary Intelligence, IQVIA, Milan, Italy
5RWD Oncology Solutions, IQVIA, London, United Kingdom
6Global Oncology, IQVIA, Reading, ENG, United Kingdom
7IQVIA, River Forest, IL

Swapna Thota, MD1, Terrence J Bradley, MD2, Hetty E. Carraway, MD, MBA3 and Elizabeth A. Griffiths, MD1

1Roswell Park Comprehensive Cancer Center, Buffalo, NY
2University of Miami Sylvester Comprehensive Cancer Center, Miami, FL
3Department of Hematology and Medical Oncology, Leukemia Program, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH

Muhammad Salman Faisal, MD, MBBS1, Laila Hashim, MBBS2*, Yazan Samhouri, MD3, Syed Maaz Abdullah, MBBS4*, Ahsan Wahab, MD5*, Moazzam Shahzad, MD6*, Hamid Ehsan, MD, MBBS7,8*, Zahoor Ahmed, MD9*, Karun Neupane, MBBS, MD10*, Asim Tameez Ud Din, MD, MBBS11*, Faiz Anwer, MD12 and Salman Fazal, MD13*

1Hematology and Stem Cell Transplant, James Cancer Hospital and Solove Research Institute, Ohio State University, Columbus, OH
2Internal Medicine, Bolan Medical Center, Quetta, Pakistan
3Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA
4King Edward Medical University, Lahore, Punjab, Pakistan
5Baptist Medical Center South, Montgomery, AL
6St Mary's Medical Center, Huntington, WV
7Georgetown University, Washington, DC
8MedStar Union Memorial Hospital, Baltimore, MD
9Department of Internal Medicine, King Edward Medical University, Lahore, Pakistan
10Manipal College of Medical Sciences, Pokhara, Nepal
11Shifa International hospital, Islamabad, Pakistan
12Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
13Allegheny Health Network Cancer Institute, Pittsburgh, PA

Seth E. Karol, MD1*, Henrique Bittencourt, MD, PhD2*, Daniel A. Morgenstern, MD3*, Margaret E. Macy, MD4*, Seong Lin Khaw, MD5, Todd M. Cooper, DO6, Arnaud Petit, MD, PhD7*, Giridharan Ramsingh, MD8*, Bo Tong, PhD9*, Kristina Unnebrink, PhD10*, Deeksha Vishwamitra, PhD9*, Fengjiao Dunbar, PhD9*, Betty A. Prine, BS9*, Tammy L. Palenski, PhD9 and Andrew E. Place, MD, PhD11

1St. Jude Children's Research Hospital, Memphis, TN
2Hematology Oncology Division, CHU Sainte-Justine, Montreal, Canada
3Hospital for Sick Children, Toronto, ON, Canada
4Department of Pediatrics, Children's Hospital Colorado and University of Colorado, Aurora, CO
5Royal Children's Hospital, Melbourne, VIC, Australia
6Seattle Children’s Hospital, Cancer and Blood Disorders Center, Seattle, WA
7Pediatric Hematology and Oncology Department, Trousseau Hospital, AP-HP, Paris, France
8Genentech, Inc., South San Francisco, CA
9AbbVie Inc., North Chicago, IL
10AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany
11Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA

Kentaro Fukushima, MD, PhD1*, SungGi Chi, MD, PhD2*, Hirohiko Shibayama, MD, PhD3, Naoko Hosono, MD, PhD4, Takahiro Yamauchi, MD, PhD4, Seiichiro Katagiri, MD, PhD5*, Akihiko Gotoh, MD, PhD6, Takanobu Morishita, M.D., Ph.D.7*, Masamitsu Yanada, MD, PhD8*, Kazuhito Yamamoto, MD, PhD8, Naohito Fujishima, MD, PhD9, Naoto Takahashi, MD, PhD9, Reiki Ogasawara, MD, PhD10*, Takeshi Kondo, MD, PhD10, Yoshikazu Utsu, MD, PhD11*, Nobuyuki Aotsuka, MD12*, Kensuke Usuki, MD, PhD13, Takaaki ONO, MD, PhD14*, Tsutomu Kobayashi, MD, PhD15*, Junya Kuroda, MD, PhD15, Hiroto Horiguchi, MD, PhD16, Satoshi Iyama, MD, PhD16*, Suguru Fukuhara, MD, PhD17*, Koji Izutsu, MD, PhD18, Makoto Nakamura, MD, PhD19*, Kensuke Kojima, MD, PhD20*, Kenichi Miyamoto, MD21,22* and Yosuke Minami, MD, PhD2

1Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, OSA, Japan
2National Cancer Center Hospital East, Kashiwa, Japan
3Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan
4University of Fukui, Fukui, Japan
57Department of Hematology, Tokyo Medical University, Tokyo, Japan
6Department of Hematology, Tokyo Medical University, Tokyo, Japan
7Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
8Aichi Cancer Center, Nagoya, Japan
9Akita University School of Medicine, Akita, Japan
10Blood Disorders Center, Aiiku Hospital, Sapporo, Japan
11Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, Narita, Japan
12Japanese Red Cross Narita Hospital, Narita, Japan
13Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan
14Hamamatsu University Hospital, Hamamatsu, Shizuoka, Japan
15Kyoto Prefectural University of Medicine, Kyoto, Japan
16Sapporo Medical University School of Medicine, Sapporo, Japan
17National Cancer Center Hospital, Tokyo, Japan
18Department of Hematology, National Cancer Center Hospital, Tokyo, Japan
19Kochi University Hospital, Nankoku, Japan
20Department of Hematology, Kochi University Hospital, Nankoku, Japan
21National Cancer Center Hospital East, Kashiwa, CHI, Japan
22Department of Medicine, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan

Qiang Liu, PhD, BSc1, Amit Subedi, PhD2, Samantha Yao3*, Changjiang Xu4*, Veronique Voisin, PhD5*, Gary D Bader4*, Steven M Chan, MD, PhD6 and Jean C.Y. Wang, MD, PhD2,7

1Princess Margaret, University Health Network, Toronto, ON, Canada
2Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
3University of Toronto, Toronto, ON, Canada
4The Donnelly Centre, University of Toronto, Toronto, ON, Canada
5Terrence Donnelly Centre for Cellular and Biomedical Research, University of Toronto, Toronto, ON, Canada
6Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
7Department of Medicine, University of Toronto, Toronto, ON, Canada

Miriam Saiz-Rodríguez1*, Beatriz Cuevas, MD, PhD2*, David Martínez-Cuadrón, MD3*, Verónica Campuzano4*, Maria Victoria Cuevas4*, Gerardo Hermida5*, Rodolfo Alvarez4*, Tomás José González-López, MD4*, Francisco Javier Diaz-Galvez4*, Raquel Alcaraz1*, Pilar de Vicente4*, Miguel A. Sanz, MD3, Pau Montesinos, MD, PhD6* and Jorge Labrador7*

1Research Unit, FBIS-Hospital Universitario de Burgos, Burgos, Spain
2Hematology Department, Hospital Universitario de Burgos, Burgos, Spain
3Hematology and hemotherapy department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
4Hospital Universitario de Burgos, Burgos, Spain
5Hospital Universitario de Burgos, Burgos, Spain, Burgos, Spain
6Hematology Department, Hospital Universitario La Fe de Valencia,, Valencia, Spain, Spain
7Hematology Department, Research Unit, Hospital Universitario de Burgos, Burgos, Spain

Gavin Hui, MD1*, Abdullah Ladha, MD2*, Edna Cheung, PharmD3*, Caroline Berube, MD4, Steven Coutre, MD4, Jason Gotlib, MD, MS4, Michaela Liedtke, MD4, Tian Y Zhang, MD, PhD4, Lori Muffly, MD, MS2 and Gabriel N. Mannis, MD4

1Department of Medicine, Stanford University, Stanford, CA
2Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA
3Department of Pharmacy, Stanford University, Stanford, CA
4Division of Hematology, Department of Medicine, Stanford University, Stanford, CA

Roberto Cairoli1*, Mauro Krampera, MD, PhD2, Patrizia Zappasodi, MD3*, Elisabetta Todisco, MD PhD4*, Erika Borlenghi, MD5*, Alfredo Molteni, MD6*, Monica Fumagalli, MD7*, Marta Ubezio8*, Massimo Bernardi, MD9*, Rosa Greco, MD1*, Erika Ravelli, MD1*, Valentina Mancini, MD1*, Giovanni Grillo, MD10*, Marta Riva11*, Beatrice De Marco12*, Adriana Cassaro, PhD13*, Bruno Brando, MD14*, Arianna Gatti14*, Silvio Marco Veronese15* and Alessandro Beghini13*

1Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
2Section of Hematology and Bone Marrow Transplant Unit, Department of Medicine, University of Verona, Verona, Italy
3Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
4European Institute of Oncology, Milano, Italy
5Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
6ASST Cremona, Cremona, Italy
7Ospedale San Gerardo, Monza, Italy
8Cancer Center, IRCCS Humanitas Research Hospital & Humanitas University, Rozzano (Milan), ITA
9Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy
10Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy, Italy
11Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, MI, Italy
12University of Verona, Verona, Italy
13Department of Health Sciences, University of Milan, Milan, Italy
14ASST Ovest Milanese, Legnano, Italy
15Azienda Ospedaliera Ospedale Niguarda Ca' Granda, Milano, Italy

*signifies non-member of ASH